Olanzapine treatment in patients with typical and atypical neuroleptic-associated agranulocytosis

被引：12

作者：

Finkel, B

Lerner, A

Oyffe, I

Rudinski, D

Sigal, M

Weizman, A

机构：

[1] Lev Hasharon Mental Hlth Med Ctr, IL-42100 Netanya, Israel

[2] Beilinson Med Ctr, Geha Psychiat Hosp, IL-49100 Petah Tiqwa, Israel

[3] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel

来源：

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 1998年 / 13卷 / 03期

关键词：

olanzapine; agranulocytosis; classic antipsychotics; clozapine; risperidone;

D O I：

10.1097/00004850-199805000-00007

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Two cases are reported of patients who developed agranulocytosis after treatment with typical and atypical antipsychotics. The patients were successfully treated with olanzapine. We suggest the consideration of olanzapine as a safer treatment in patients who require immediate continuation of antipsychotic medication and have a prior history of classic and atypical neuroleptic-induced agranulocytosis. Int Clin Psychopharmacol 13:133-135 (C) 1998 Lippincott-Raven Publishers.

引用

收藏

页码：133 / 135

页数：3

相关论文

共 11 条

[1] CLOZAPINE-INDUCED AGRANULOCYTOSIS - INCIDENCE AND RISK-FACTORS IN THE UNITED-STATES [J].

ALVIR, JMJ ;

LIEBERMAN, JA ;

SAFFERMAN, AZ ;

SCHWIMMER, JL ;

SCHAAF, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (03) :162-167

[2] USUAL AND UNUSUAL AGRANULOCYTOSIS DURING NEUROLEPTIC THERAPY [J].

ANANTH, JV ;

VALLESSJ. ;

WHITELAW, JP .

AMERICAN JOURNAL OF PSYCHIATRY, 1973, 130 (01) :100-102

[3] Olanzapine versus placebo and haloperidol - Acute phase results of the North American double-blind olanzapine trial [J].

Beasley, CM ;

Tollefson, G ;

Tran, P ;

Satterlee, W ;

Sanger, T ;

Hamilton, S ;

Fabre, L ;

Small, J ;

Ereshefsky, L ;

True, J ;

Nemeroff, C ;

Risch, SC ;

Perry, PJ ;

Potkin, SG ;

Borison, RL ;

James, S ;

Meltzer, HY ;

Iqbal, N ;

Fann, WE ;

Gewirtz, GR ;

Landbloom, R ;

RoyByrne, PP ;

Tuason, VB ;

Carman, JS ;

Stokes, PE ;

Williams, R ;

Ancill, RJ ;

MacEwan, GW ;

Gujavarty, KS ;

Jones, B ;

Lohr, JB .

NEUROPSYCHOPHARMACOLOGY, 1996, 14 (02) :111-123

[4] Olanzapine - A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses [J].

Fulton, B ;

Goa, KL .

DRUGS, 1997, 53 (02) :281-298

[5]

Gerson S L, 1992, Drug Saf, V7 Suppl 1, P17

[6]

Godleski LS, 1996, AM J PSYCHIAT, V153, P735

[7] Does eosinophilia predict clozapine induced neutropenia? [J].

Hummer, M ;

SpernerUnterweger, B ;

Kemmler, G ;

Falk, M ;

Kurz, M ;

Oberbauer, H ;

Fleischhacker, WW .

PSYCHOPHARMACOLOGY, 1996, 124 (1-2) :201-204

[8]

LIEBERMAN JA, 1990, ARCH GEN PSYCHIAT, V47, P945

[9] Risperidone appears safe in patients with antipsychotic-induced blood dyscrasias [J].

Mahmood, T ;

Silverstone, T ;

Spittle, B .

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1996, 11 (01) :53-54

[10] DRUG-INDUCED AGRANULOCYTOSIS [J].

PISCIOTTA, V .

DRUGS, 1978, 15 (02) :132-143